NYU Langone Health: Alzheimer Disease trials

The registry lists 22 Alzheimer Disease studies with NYU Langone Health as lead sponsor. 2 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 1Phase 4 4No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Innate Immunity Stimulation Via TLR9 in Early ADRecruitingNCT05606341Phase 1
• Aβ Dynamics in LLMDRecruitingNCT05004987Phase 4
• Enhanced Quality in Primary Care for Elders With Diabetes and DementiaCompletedNCT03723707Not applicableResults posted
• Detecting an Early Response to Donepezil With Measures of Visual AttentionCompletedNCT03073876Phase 4Results posted
• Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's DiseaseCompletedNCT00933608Phase 4Results posted
• Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver TrainingCompletedNCT00120874Phase 4Results posted
• ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia CareActive, not recruitingNCT06079203Not applicable
• Couples Lived ExperienceCompletedNCT04863495
• Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)Active, not recruitingNCT04784416Phase 2
• Locus-coeruleus Function in Normal Elderly and AD RiskCompletedNCT04403165Not applicable
• PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITIONCompletedNCT03999879
• Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive ImpairmentCompletedNCT03912571
• The Sleep Amyloid, Slow WAve Race and Ethnicity StudyCompletedNCT03814603
• Developing Advanced Blood-Brain Barrier Permeability Imaging for Early ADCompletedNCT03389698
• Sleep Aging and Risk for Alzheimer's 2.0Active, not recruitingNCT03278119
• A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 FlutemetamolTerminatedNCT03274817Phase 1
• Orexin and Tau Pathology in Cognitively Normal ElderlyCompletedNCT03053908Not applicable
• Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health OutcomeCompletedNCT02854917
• Brain Sleep Deprivation MRI Effects (BEDTIME)WithdrawnNCT02741505Not applicable
• Brain Sleep Clearance of Amyloid-Beta PeptidesCompletedNCT02474251Not applicable
• Tools for Distance Delivery of an Evidence-based AD Family Caregiver InterventionCompletedNCT02347202Not applicable
• Sleep, Aging and Risk for Alzheimer's DiseaseCompletedNCT01962779Not applicable